Beta Drugs Limited — Others, 06-02-2025: Shareholders meeting

Beta Drugs Ltd. has submitted a notice for a postal ballot seeking shareholder approval for key resolutions, including an increase in authorized share capital from INR 10.5 crore to INR 11 crore to facilitate a proposed bonus issue of shares. The company plans to issue bonus shares at a ratio of 1:20, equating to approximately INR 51.6 lakh from its reserves. Additionally, the board proposes the appointments of Monica Jain and Lalit Kumar Watts as independent directors for five-year terms. The company aims to migrate its shares from the Emerge platform to the main boards of NSE and BSE, which could enhance its visibility and investor engagement. This migration presents a positive outlook for shareholders, indicating growth potential and increased liquidity.